已收盤 04-02 16:00:00 美东时间
+0.160
+1.42%
今日重点评级关注:Piper Sandler:维持Allogene疗法"超配"评级,目标价从7美元升至8美元;B. Riley证券:维持Oncology Institute"买入"评级,目标价从6美元升至8美元
03-16 18:19
今日重点评级关注:Oppenheimer:维持Corbus制药控股"跑赢大市"评级,目标价从53美元升至57美元;Canaccord Genuity:维持WAVE Life Sciences"买入"评级,目标价从43美元升至52美元
03-11 12:40
Keefe, Bruyette & Woods analyst Paul Johnson maintains MidCap Financial (NASDAQ:MFIC) with a Market Perform and lowers the price target from $13 to $11.5.
03-10 20:19
今日重点评级关注:韦德布什:维持TScan Therapeutics"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持莱斯康制药"买入"评级,目标价从4美元升至6美元
03-06 11:58
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
MidCap Financial reduced its dividend and re-evaulated its assets due to challenges in segments of its loan portfolio.
02-28 04:37
Shares of companies within the broader financial sector are trading lower amid ...
02-28 04:17
MidCap Financial (NASDAQ:MFIC) announced its Q3 earnings on Thursday, February ...
02-27 05:04
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33